ID
25709
Beskrivning
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome
Nyckelord
Versioner (2)
- 2017-09-11 2017-09-11 -
- 2017-09-12 2017-09-12 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
11 september 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
visit 1,2,3 & 4 dosing details PK and tolerability of ropinirole as 5 new formulations 101468/197
visit 1,2,3 & 4 dosing details PK and tolerability of ropinirole as 5 new formulations 101468/197
Beskrivning
Dosing Details
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0178602
Beskrivning
time of dosing
Datatyp
time
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C0040223
Beskrivning
dose checked
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1283174
Beskrivning
dose administered
Datatyp
text
Alias
- UMLS CUI [1]
- C2348343
Beskrivning
Please tick the appropriate treatment.
Datatyp
text
Alias
- UMLS CUI [1]
- C0087111
Similar models
visit 1,2,3 & 4 dosing details PK and tolerability of ropinirole as 5 new formulations 101468/197
C0040223 (UMLS CUI [1,2])
C1283174 (UMLS CUI [1,2])